Study of IL28B gene variation as a predictor of response to Directly Acting antiviral therapy in Hepatic transplantation Hepatitis C Egyptian Patients
Shady Samir AbdelHamid Ghait;
Abstract
ABSTRACT
Background: IL28B gene polymorphisms are associated with the response to antiviral therapy in hepatitis C patients in the non-transplant setting.
Objective: To determine the prevalence and impact on clinical outcomes of donor and recipient IL28B genotypes among liver transplant recipients receiving directly acting antiviral therapy compared to those of HCV non-transplant patients.
Background: IL28B gene polymorphisms are associated with the response to antiviral therapy in hepatitis C patients in the non-transplant setting.
Objective: To determine the prevalence and impact on clinical outcomes of donor and recipient IL28B genotypes among liver transplant recipients receiving directly acting antiviral therapy compared to those of HCV non-transplant patients.
Other data
| Title | Study of IL28B gene variation as a predictor of response to Directly Acting antiviral therapy in Hepatic transplantation Hepatitis C Egyptian Patients | Other Titles | دراسة الأختلاف الجينى للانترليوكين 28-ب لتنبؤ الاستجابة للأدوية المباشرة المضادة لفيروس سى عن طريق الفم فى مرضى فيروس سى المصريين بعد زراعة الكبد | Authors | Shady Samir AbdelHamid Ghait | Issue Date | 2019 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.